
Less
Expensive But Equally Effective Antibiotics To Treat Ear Infections Could
Reduce Medicaid Expenditures
Contact: AHCPR Public Affairs, (301) 594-1364:
Karen Carp, ext. 1378
Venese DeJernett, ext. 1317
Source: Agency for Health Care Policy and Research (AHCPR)
October 6, 1997
Treating common ear infections in children with antibiotics such as amoxicillin
instead of more costly choices could save millions of dollars a year without
changing recovery rates, according to researchers supported by the federal
Agency for Health Care Policy and Research. Their study, which looked at
children covered under Colorado's Medicaid program, is published in the
October issue of Pediatrics.
Middle ear infectionor otitis mediais the most frequent reason for giving
antibiotics to children in the United States. Doctors can select from a
large number of antibiotics, but no single antibiotic has been found to
be superior to another for treating this condition. However, costs vary
widely, from $2.94 to $62.80, for example, for a 10-day course of antibiotics
for a 19 to 24-month-old child.
Researchers found that more expensive antibiotics, such as amoxicillin/clavulanate
or cephalosporins, accounted for only 30 percent of the prescriptions written
for the studied population, but up to 77 percent of the more than $2 million
spent for medications. In contrast, amoxicillin and other less expensive
antibiotics, which worked just as well, accounted for 67 percent of the
prescriptions but only 21 percent of the costs. There were no financial
incentives or disincentives to influence physicians to choose one antibiotic
over another. In general, hospital outpatient department and community
health center doctors tended to prescribe less expensive antibiotics while
their office-based counterparts generally prescribed more expensive ones.
According to the investigators, if, in 1992, only half the prescriptions
in the study for cefaclor, cefixine, and amoxicillin/clavulanate instead
had been written for amoxicillin alone, Colorado's Medicaid program would
have saved $399,412.
The study, conducted by Stephen Berman, MD and other researchers at the
University of Colorado Health Sciences Center, looked at 12,381 children
13 years of age and younger who were enrolled in Colorado's fee-for-service
Medicaid program, and who were treated for a new episode of acute otitis
media in 1991 and 1992. The article, entitled "Otitis Media-related
Antibiotic Prescribing Patterns, Outcomes, and Expenditures in a Pediatric
Medicaid Population," was a component of AHCPR's Pharmaceutical Outcomes
Research Program.
AiA Home
Site Contents
American Iatrogenic Association
2513 S. Gessner, #232
Houston, Texas 77063
www.iatrogenic.org
aia@iatrogenic.org